ABBOTT LABORATORIES — Director's Dealing 2014

Mar 4, 2014

Page 1 of 1

SEC FORM 4

SEC Form 4 FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 December 31, Expires: 2014

Estimated average burden hours per 0.5 response:

1. Name and Address of Reporting Person* Blaser Brian J (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)	1. Name and Address of Reporting Person* Blaser Brian J (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)	1. Name and Address of Reporting Person* Blaser Brian J (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)	1. Name and Address of Reporting Person* Blaser Brian J (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ ABT]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President
				3. Date of Earliest Transaction (Month/Day/Year) 02/28/2014
				4. If Amendment, Date of Original Filed (Month/Day/Year)													6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)				2. Transaction Date (Month/Day/Year)			2A. Deemed Execution Date, if any (Month/Day/Year)			3. Transaction Code (Instr. 8)			4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)							5. Amount of Securities Beneficially Owned Following Reported Transaction (s) (Instr. 3 and 4)		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)		7. Nature of Indirect Beneficial Ownership (Instr. 4)
										Code		V	Amount			(A) or (D)		Price
Common shares without par value				02/28/2014						F			13,097			D		$ 39.79		104,336		D
Common shares without par value				03/03/2014						S			1,441			D		$ 39.014		102,895		D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			6. Date Exercisable and Expiration Date (Month/Day/Year)					7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)					8. Price of Derivative Security (Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction (s) (Instr. 4)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)		11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)		(D)	Date Exercisable		Expiration Date			Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

John A. Berry, by power of 03/04/2014 attorney for Brian J. Blaser ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

3/4/2014